NCT00963027
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- PPD Development Austin, Texas, United States
Clinical trial condition
Pulmonary Arterial Hypertension
Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.
354 public trials
45 recruiting studies
Pulmonary Arterial Hypertension trial results
NCT00963001
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- PPD Development Austin, Texas, United States
Completed
Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
NCT00423748
- Conditions
- Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
- Locations
-
Not specified
NCT00423202
- Conditions
- Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
- Locations
-
Not specified
Active, Not Recruiting
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
NCT04816604
- Conditions
- Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
- Locations
-
- University of California, Davis Medical Center Sacramento, California, United States
- Medical Corporation Santa Barbara, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Cleveland Clinic Florida Weston, Florida, United States
Active, Not Recruiting
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
NCT05649748
- Conditions
- Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
- Locations
-
- USA005 Jacksonville, Florida, United States
- USA011 Tampa, Florida, United States
- USA006 Chicago, Illinois, United States
- USA001 Chicago, Illinois, United States
Active, Not Recruiting
A Study of Pulmonary Hypertension Peripheral Limitations
NCT05968859
- Conditions
- Healthy, Hypertension, Pulmonary, Lung Diseases, +2 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
NCT04273945
- Conditions
- Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Arizona Pulmonary Specialists, Ltd Scottsdale, Arizona, United States
- Scripps Memorial Hospital La Jolla, California, United States
- USC Keck Los Angeles, California, United States
Active, Not Recruiting
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
NCT03492177
- Conditions
- Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
- Locations
-
- Children'S Hospital Cardiac Care Center University Of Colorado Aurora, Colorado, United States
- University of Iowa Hospital Iowa City, Iowa, United States
- Seattle Children's Hospital Seattle, Washington, United States
- State Institution Republican Scientific And Practical Center For Pediatric Surgery Minsk, Belarus
Active, Not Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
NCT06274801
- Conditions
- Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
- Locations
-
- Valley Advanced Lung Diseases Institute Fresno, California, United States
- Department of Veterans Affairs Greater Los Angeles Healthcare System Los Angeles, California, United States
- UC Davis Health Medical Center Sacramento, California, United States
- Stanford Healthcare Stanford, California, United States